Darren S Cline
CIK 1633639 · Chief Commercial Officer · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$754.2K
Companies
7
Total Filings
52
Lifetime Open-Market Net
-$5.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLRX | Director | — | $1.07 | — | $0 | 5 | 2026-06-12 |
| PYXS | Director | 251,405 | $3.00 | $754.2K | $93.9K | 7 | 2026-03-25 |
| XENE | Chief Commercial Officer | — | $63.52 | — | $0 | 2 | 2026-01-09 |
| IPI Legacy Liquidation Co (IMPL) Delisted | Director | — | $0.24 | — | $0 | 2 | 2023-06-20 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | U.S. Chief Commercial Officer | 5,556 | $218.96 | $1.22M | $0 | 5 | 2021-03-04 |
| STEMLINE THERAPEUTICS INC (STML) Delisted | Director | 0 | — | — | $0 | 3 | 2020-06-10 |
| Seagen Inc. (SGEN) Delisted | EVP, Commercial | 72,556 | $228.74 | $16.60M | -$5.46M | 27 | 2018-11-30 |
Recent Filings · Page 6 of 6
52 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-08-25 | Seagen Inc. (SGEN) Delisted | Mixed | +9,769 | -$93.8K | EDGAR |
| 2015-03-17 | Seagen Inc. (SGEN) Delisted | Sell (S) | −7,500 | -$289.9K | EDGAR |
Showing 51–52 of 52
Prev
Page 6 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.